SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-157279
Filing Date
2020-06-01
Accepted
2020-06-01 16:20:40
Documents
12
Period of Report
2020-05-29
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d909350d8k.htm   iXBRL 8-K 37498
  Complete submission text file 0001193125-20-157279.txt   160437

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rgnx-20200529.xsd EX-101.SCH 3059
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgnx-20200529_lab.xml EX-101.LAB 18137
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgnx-20200529_pre.xml EX-101.PRE 11400
5 EXTRACTED XBRL INSTANCE DOCUMENT d909350d8k_htm.xml XML 3349
Mailing Address 9600 BLACKWELL ROAD SUITE 210 ROCKVILLE MD 20850
Business Address 9600 BLACKWELL ROAD SUITE 210 ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Filer) CIK: 0001590877 (see all company filings)

IRS No.: 471851754 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37553 | Film No.: 20933646
SIC: 2836 Biological Products, (No Diagnostic Substances)